Naar homepage     
Chronische Cerebro-Spinale Veneuze Insufficiëntie
Aanmelden op het CCSVI.nl forum
Lees Voor (ReadSpeaker)    A-   A+
Over CCSVI.nl | Zoeken | Contact | Forum
PayPal, de veilige en complete manier van online betalen.

iDeal
CCSVI.nl is onderdeel van de
Franz Schelling Stichting
meer informatie
  
Friday, May 11, 2012 12:50 AM | CCSVI in Multiple Sclerosis Volg link
Several approved studies are underway, including work at UBC, and another study in Albany New York, partially funded by the province of Saskatchewan.
The FDA's warning does not affect Saskatchewan MS patients traveling to participate in the clinical trial at the Albany Medical Center, a spokesperson for the government of Saskatchewan wrote to CTV . The FDA Gave final approval to the research protocol May 4, 2012.


FDA warns against unapproved 'liberation' studies | CTV News
www.ctv.ca
The U.S. Food and Drug Administration has issued a warning to U.S. clinics performing studies on angioplasty as a treatment for multiple sclerosis, saying any studies on the procedure need FDA approval.